post hoc of the PEXIVAS study 704 participants w/ severe ANCA vasculitis: 92% achieved remission & 23% had relapses (rate 10.3/100PYs)-- Neither plasma exchange nor glucocorticoid tapering regimen impacted relapse risk. https://t.co/UN6RujwZKc https://t.co/MsXKPwp9km
Links:
The risk of relapse of ANCA‐associated vasculitis in a randomized controlled tr…
https://buff.ly/4cnsHAh
Mar-21-2024
